WASHINGTON (AP) — Federal well being officers on Wednesday approved a brand new COVID-19 antibody drug for folks with severe well being issues or allergy symptoms who can’t get enough safety from vaccination.
Antibody medication have been an ordinary remedy for treating COVID-19 infections for over a yr. However the AstraZeneca antibody drug cleared Wednesday by the Meals and Drug Administration is totally different. It’s the primary approved for long-term prevention towards COVID-19 an infection, reasonably than a short-term remedy.
Individuals who may benefit from the antibody drug embody most cancers sufferers, organ transplant recipients and folks taking immune-suppressing medication for situations like rheumatoid arthritis. Well being specialists estimate about 2 p.c to three p.c of the U.S. inhabitants falls into that group.
“These folks nonetheless should shelter in place as a result of they’re at actually excessive threat of extreme illness and loss of life,” stated Dr. David Boulware of the College of Minnesota, forward of the announcement. “So having this remedy will allow lots of them to get again to their regular lives.”
Particularly, the FDA approved the AstraZeneca drug known as Evusheld for adults and kids 12 and older whose immune programs haven’t responded adequately to COVID-19 vaccines or have a historical past of extreme allergic reactions to the photographs. Regulators stated the required two antibody injections could also be efficient at stopping COVID-19 infections for six months.
Like comparable medication, AstraZeneca’s delivers laboratory-made variations of human antibody proteins, which assist the immune system struggle off viruses and different infections.
WATCH: May omicron result in extra breakthrough COVID circumstances? Right here’s what we all know
The FDA and different well being authorities have burdened that antibody medication aren’t an alternative to vaccines, that are the best, long-lasting and economical type of virus safety. Antibody medication are tough to fabricate and infrequently price greater than $1,000 per dose in contrast with vaccines which can be sometimes beneath $30 per shot.
The FDA has approved three different antibody therapies from Regeneron, Eli Lilly and GlaxoSmithKline, with the U.S. authorities buying a whole bunch of hundreds of doses. All require an IV or injection. They’re used to deal with folks with current infections who’ve the best threat of progressing to extreme COVID-19 due to different well being points. Two can be utilized to forestall an infection after a doable coronavirus publicity.
AstraZeneca’s drug could be used in another way— solely as a long-term safety measure in individuals who have elevated vulnerability to the virus.
In an organization examine, individuals who obtained Evusheld had a 77 p.c decrease threat of an infection than individuals who obtained a dummy shot over six months, the FDA stated.